Benzimidazole condensed ring systems. XII. Synthesis and anticancer evaluation of certain pyrido[1,2-a]benzimidazole derivatives

Pharmazie

Volumn 54, Issue 5, 1999, Pages 341-346

  El Hawash, S A M ^a   Badawey, El Sayed A M ^a   Kappe, T ^b  

^a Alexandria University Faculty of Pharmacy   (Egypt)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

1 (3 TRIFLUOROMETHYL)AMINO 3 PHENYLPYRIDO[1,2 A]BENZIMIDAZOLE 4 CARBONITRILE; 1 (4 CHLOROPHENYL)AMINO 3 PHENYLPYRIDO[1,2 A]BENZIMIDAZOLE 4 CARBONITRILE; 1 (4 FLUOROPHENYL)AMINO 3 PHENYLPYRIDO[1,2 A]BENZIMIDAZOLE 4 CARBONITRILE; 1H BENZIMIDAZOLE 2 ACETONITRILE; 2 (3 TRIFLUOROMETHYL)AZO 1 OXO 1H,5H 3 PHENYLPYRIDO[1,2 A]BENZIMIDAZOLE 4 CARBONITRILE; 2 (4 FLUOROPHENYL)AZO 1 OXO 1H,5H 3 PHENYLPYRIDO[1,2 A]BENZIMIDAZOLE 4 CARBONITRILE; 4 (4 FLUOROPHENYL)AMINO 2,3 DIHYDRO 1H CYCLOPENTAL[4',5':2,3]PYRIDO [1,2 A]BENZIMIDAZOLE 11 CARBONITRILE; ANTINEOPLASTIC AGENT; BENZIMIDAZOLE DERIVATIVE; NSC 649900; NSC 682011; NSC 699940; NSC 699944; NSC 699946; NSC 699948; NSC 699956; NSC 699959; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ANTINEOPLASTIC AGENTS; BENZIMIDAZOLES; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0032962455     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Morgan, G. T.; Stewart, J.: Chem. Ind. 670 (1937); CA. 31, 7424 (1937)
2. Morgan, G. T.; Stewart, J.: Chem. Ind. 670 (1937); CA. 31, 7424 (1937)
3. Badawey, E. A. M.; Gohar, Y.: Farmaco 47, 489 (1992)
4. Hammad, M.; Abdel Meguid, S.; El-Ananni, M.; Shafik, N.: Egypt J. Chem. 29, 549 (1987)
5. Shigeta, S.; Mori, S.; Baba, M.; Hosoya, M.; Mochizuki, N.; Chiba, T.; De Clerq, E.: Antiviral Chem. Chemother. 3, 171 (1992); C.A. 117, 82936f (1992)
6. Shigeta, S.; Mori, S.; Baba, M.; Hosoya, M.; Mochizuki, N.; Chiba, T.; De Clerq, E.: Antiviral Chem. Chemother. 3, 171 (1992); C.A. 117, 82936f (1992)
7. Chiba, T.; Shigeta, S.; Numazaki, Y.: Biol. Pharm. Bull. 18, 1081 (1995); C.A. 123, 246 152z (1995)
8. Chiba, T.; Shigeta, S.; Numazaki, Y.: Biol. Pharm. Bull. 18, 1081 (1995); C.A. 123, 246 152z (1995)
9. Alpermann, H. G.: Arzneim.-Forsch. 16, 1641 (1966)
10. Yamanouchi Pharmaceutical Co., Ltd.: Jpn. KoKai Tokkyo Koho 8085, 595 (C1 C07D 513/04), (1980); C.A. 94, 47326s (1981)
11. Kubo, K.; Ito, N.; Isomura, Y.; Sozu, I.; Homma, H.; Murakami, M.: Yakugaku Zasshi 99, 880 (1979), C.A. 92, 58685t (1980)
12. Kubo, K.; Ito, N.; Isomura, Y.; Sozu, I.; Homma, H.; Murakami, M.: Yakugaku Zasshi 99, 880 (1979), C.A. 92, 58685t (1980)
13. Maryanoff, B. E.; Ho, W.; McComsey, D. F.; Reitz, A. B.; Grous, P. P; Nortey, S. O.; Shank, R. P.; Dubinsky, B.; Taylor, R. J.; Gardocki, J. F.: J. Med. Chem. 38, 15 (1995)
14. Rida, S. M.; Soliman, F. S. G.; Badawey, E. A. M.; El-Ghazzawi, E.; Kader, O.; Kappe, T.: J. Heterocycl. Chem. 25, 1087 (1988)
15. Badawey, E. A. M.; Rida, S. M.; Soliman, F. S. G.; Kappe, T.: Monatsh. Chem. 120, 73 (1989)
16. Rida, S. M.; Soliman, F. S. G.; Badawey, E. A. M.; Kappe, T.: J. Heterocycl. Chem. 25, 1725 (1988)
17. Badawey, E. A. M.; Kappe, T.: Eur. J. Med. Chem. 30, 327 (1995)
18. Badawey, E. A. M.; Kappe, T.: Farmaco 50, 537 (1995)
19. Badawey, E. A. M.; Kappe, T.: 6th Ibn Sina International Conference on pure and applied Heterocyclic Chemistry, December 1997; Eur. J. Med. Chem., submitted
20. Badawey, E. A. M.; Kappe, T.: 6th Ibn Sina International Conference on pure and applied Heterocyclic Chemistry, December 1997; Eur. J. Med. Chem., submitted
21. Grever, M. R.; Schepartz, S. A.; Chabner, B. A.: Seminar in Oncology 19, 622 (1992)